A big player in Bayer’s stock is preparing to sell off a huge chunk of its shares, sparking curiosity about what this means for the company’s future. Reports show the investor intends to unload about 8. 5 million shares through JPMorgan Chase, a move that could bring in roughly 327 million euros bas
Barclays released a report that shows how companies seen as lagging behind AI are losing value fast. The decline is so sharp that an activist investor, known for buying stakes in struggling firms, may be stepping in. Barclays says the sharp drop creates chances in software, media, internet and
In the world of finance, things are always changing. Recently, a well-known activist investor, Jana Partners, has been making waves. They've quietly built up a significant stake in Alkami Technology, a company that specializes in banking tech. This move didn't go unnoticed. It's a clear sign that Ja
Kenvue, the company behind popular brands like Tylenol and Neutrogena, is going through some big changes. The CEO, Thibaut Mongon, has stepped down. This is the second major leadership change in a short time. The company is under pressure from investors to improve its performance, especially in its
Investors are keeping a close eye on Macy's. The retail giant recently shared its fourth-quarter earnings, which were a mix of good and bad news. The company's total sales dropped by 4% compared to the same period last year. This drop was partly due to an extra selling week in the previous year, whi
Costco's shareholders recently shot down a proposal questioning the wholesale club's diversity, equity, and inclusion (DEI) policies. The activist investors leading the charge, however, aren't ready to throw in the towel just yet. Ethan Peck, deputy director of the National Center for Public Policy
Markel Group, a financial holding company, is known for its specialty insurance, investments, and a diverse range of businesses under Markel Ventures. Recently, activist investor Jana Partners, led by Barry Rosenstein, has been urging the company to focus more on its insurance operations. Markel's i
Elliott Management, an activist investor, has a massive $5 billion stake in Honeywell. They're pushing for a big change: splitting the company into two. The idea is to create one company for aerospace stuff, like engines and avionics, and another for automation, like sensors and control systems. Ell
Pfizer recently shared impressive Q3 results that overshot expectations, thanks to its Covid vaccine and antiviral pill, Paxlovid. The drug giant raised its earnings and revenue projections for the year. Despite the positive news, shares dropped by over 2%. Pfizer's CEO, Albert Bourla, is under pres
Pfizer's third-quarter earnings just came in, and guess what? They're way better than expected! The company's making a lot more money, thanks to a big demand for their COVID-19 treatments. Their best-selling drug, Paxlovid, brought in a whopping $2. 7 billion in the third quarter alone. This is a ma
